Uveitis: Diagnosis and Management

A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Medical Imaging and Theranostics".

Deadline for manuscript submissions: 30 June 2024 | Viewed by 1500

Special Issue Editor


E-Mail Website
Guest Editor
Ophthalmologia Department, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal
Interests: clinical ophthalmology; cataract surgery; retinal diseases; eye diseases; uveitis; ophthalmology; eyes

Special Issue Information

Dear Colleagues,

This section of Diagnostics aims to facilitate the rapid publication of contributions on the diagnosis and management of uveitis. Topics include, but are not limited to, the following:

  • infectious uveitis;
  • non-infectious uveitis;
  • OCT and OCT-A in uveitis;
  • fluorescein and green indocyanine angiography in uveitis;
  • ultrasound in uveitis;
  • the surgical management of uveitis complications (glaucoma, uveitic cataracts, and retinal structural complications);
  • immunomodulation in uveitis;
  • microbiome and uveitis;
  • pediatric uveitis;
  • COVID-19 and uveal manifestations;
  • deep learning and artificial intelligence in uveitis;
  • uveitis in a low-resource settings;
  • uveitis in immunosuppressed patients.

Dr. Leal Ines
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

48 pages, 1380 KiB  
Review
Diagnosing and Managing Uveitis Associated with Immune Checkpoint Inhibitors: A Review
by Huixin Zhang, Lysa Houadj, Kevin Y. Wu and Simon D. Tran
Diagnostics 2024, 14(3), 336; https://doi.org/10.3390/diagnostics14030336 - 04 Feb 2024
Cited by 1 | Viewed by 1197
Abstract
This review aims to provide an understanding of the diagnostic and therapeutic challenges of uveitis associated with immune checkpoint inhibitors (ICI). In the wake of these molecules being increasingly employed as a treatment against different cancers, cases of uveitis post-ICI therapy have also [...] Read more.
This review aims to provide an understanding of the diagnostic and therapeutic challenges of uveitis associated with immune checkpoint inhibitors (ICI). In the wake of these molecules being increasingly employed as a treatment against different cancers, cases of uveitis post-ICI therapy have also been increasingly reported in the literature, warranting an extensive exploration of the clinical presentations, risk factors, and pathophysiological mechanisms of ICI-induced uveitis. This review further provides an understanding of the association between ICIs and uveitis, and assesses the efficacy of current diagnostic tools, underscoring the need for advanced techniques to enable early detection and accurate assessment. Further, it investigates the therapeutic strategies for ICI-related uveitis, weighing the benefits and limitations of existing treatment regimens, and discussing current challenges and emerging therapies in the context of their potential efficacy and side effects. Through an overview of the short-term and long-term outcomes, this article suggests recommendations and emphasizes the importance of multidisciplinary collaboration between ophthalmologists and oncologists. Finally, the review highlights promising avenues for future research and development in the field, potentially informing transformative approaches in the ocular assessment of patients under immunotherapy and the management of uveitis following ICI therapy. Full article
(This article belongs to the Special Issue Uveitis: Diagnosis and Management)
Show Figures

Figure 1

Back to TopTop